[Home](https://github.com/mm80843/T3.5/blob/pages/index.md) >> Class: [Risk](https://github.com/mm80843/T3.5/tree/main/docs/Risk/index.md) >> Individual ID:PBN__Risk_2277 

# __Lack of covid-19 vaccine__

## Articles mentionning the risk

* [The impact of COVID-19 and strategies for mitigation and suppression in low- and middle-income countries](https://github.com/mm80843/T3.5/blob/pages/Article/PBN__Article_65.md)

## Category to which it belongs

* [The wide-ranging impacts of the covid-19 pandemic, from its spread in urban areas to its economic, social, and psychological consequences, call for urgent and effective crisis management.](https://github.com/mm80843/T3.5/blob/pages/PBNCategory/PBN__PBNCategory_69.md)

## Closest similar item

* [Lack of drug therapies for covid-19](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_1483.md)
* [Lack of drugs and vaccines](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_54.md)
* [Lack of knowledge about the virus, treatments, and vaccines](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_1733.md)
* [Lack of knowledge on covid-19](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_624.md)
* [Lack of medication and vaccines for covid-19](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_821.md)
* [Lack of patient education for covid-19](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_935.md)
* [Lack of vaccine or cure](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_3118.md)
* [Limited availability of medication and vaccines for covid-19](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_1341.md)
* [Poor practices for covid-19 prevention](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_2879.md)
* [Vaccine availability, vaccine hesitancy](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_626.md)

## Description of the risk

The absence of a vaccine against COVID-19

## Is the risk affecting GBN scales

* [No](https://github.com/mm80843/T3.5/blob/pages/ISO/PBN__ISO_Scale_0.md)

## Mitigations of this risk

* [Development and distribution of an effective vaccine](https://github.com/mm80843/T3.5/blob/pages/Mitigation/PBN__Mitigation_2989.md)

## Name of the risk

Continued transmission of the virus, high number of infections and deaths

## People affected by this risk

* [General population](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_9.md)

## Stakeholders who can mitigate this risk

* [Government](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_73.md)
* [Pharmaceutical companies](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_124.md)

## Technologies linked to the risk

* [Vaccine development and manufacturing](https://github.com/mm80843/T3.5/blob/pages/Technology/PBN__Technology_1883.md)

## Type of impact of the risk (according to ISO37100)

* [Health and care](https://github.com/mm80843/T3.5/blob/pages/ISO/PBN__ISO_Purpose_0.md)

## Type of purpose of the risk (according to ISO37100)

* [Resilience](https://github.com/mm80843/T3.5/blob/pages/ISO/PBN__ISO_Impact_2.md)

## Type of the risk

* [Physical](https://github.com/mm80843/T3.5/blob/pages/RiskHealth/PBN__RiskHealth_0.md)

## Property: has_RiskType

* [Technological](https://github.com/mm80843/T3.5/blob/pages/RiskType/PBN__RiskType_5.md)

